Therefore, the present review raises the need for further in-depth studies on tau pathology in oligodendrocytes that will enrich our current knowledge and benefit future designing of novel tau-targeted therapeutic strategies to prevent human tauopathies. The gene discussed is MAPT; the disease is tauopathy.